全文获取类型
收费全文 | 2538篇 |
免费 | 189篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 101篇 |
妇产科学 | 45篇 |
基础医学 | 493篇 |
口腔科学 | 41篇 |
临床医学 | 241篇 |
内科学 | 392篇 |
皮肤病学 | 112篇 |
神经病学 | 271篇 |
特种医学 | 83篇 |
外科学 | 176篇 |
综合类 | 13篇 |
预防医学 | 221篇 |
眼科学 | 55篇 |
药学 | 242篇 |
中国医学 | 7篇 |
肿瘤学 | 236篇 |
出版年
2024年 | 1篇 |
2023年 | 29篇 |
2022年 | 95篇 |
2021年 | 137篇 |
2020年 | 83篇 |
2019年 | 95篇 |
2018年 | 114篇 |
2017年 | 86篇 |
2016年 | 85篇 |
2015年 | 95篇 |
2014年 | 104篇 |
2013年 | 148篇 |
2012年 | 222篇 |
2011年 | 217篇 |
2010年 | 138篇 |
2009年 | 101篇 |
2008年 | 168篇 |
2007年 | 181篇 |
2006年 | 128篇 |
2005年 | 142篇 |
2004年 | 90篇 |
2003年 | 87篇 |
2002年 | 84篇 |
2001年 | 12篇 |
2000年 | 14篇 |
1999年 | 10篇 |
1998年 | 12篇 |
1997年 | 12篇 |
1996年 | 5篇 |
1995年 | 10篇 |
1994年 | 2篇 |
1993年 | 6篇 |
1992年 | 1篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1989年 | 2篇 |
1988年 | 3篇 |
1987年 | 2篇 |
1985年 | 2篇 |
1984年 | 2篇 |
1983年 | 2篇 |
1982年 | 3篇 |
1980年 | 2篇 |
1978年 | 3篇 |
1977年 | 1篇 |
1973年 | 1篇 |
1970年 | 1篇 |
1969年 | 1篇 |
排序方式: 共有2742条查询结果,搜索用时 0 毫秒
61.
62.
63.
Antiphospholipid autoantibodies particularly antibodies against beta2-glycoprotein I (anti-beta2GPI) are casually associated with thromboses in patients with autoimmune diseases. However, their exact prevalence and role in the pathogenesis of thromboses in the absence of autoimmune disease is still inconclusive. They might be particularly important when other risk factors of thrombosis are absent. We investigated antiphospholipid antibodies in 68 young women (aged <45yr at onset of the event, without autoimmune disease and with an otherwise low risk of thrombosis) in the stable period following myocardial infarction (MI), lacunar cerebral infarction (LACI) or deep vein thrombosis (DVT) and in 37 healthy age-matched controls. Patients had increased IgM anti-beta2GPI compared to controls (36.0, 11.5-49.5 vs. 17.50, 3.50-30.0 arbitrary units (AU), p<0.001), whereas no difference was obtained in other measured antibodies (anticardiolipin and antiphosphatidylserine (aPS) antibodies of IgG and IgM). IgM anti-beta2GPI positively correlated with some markers of increased coagulation potential and negatively with BMI (r=-039, p<0.005) and other parameters of the metabolic syndrome. In conclusion, we found that levels of IgM anti-beta2GPI are increased in young women suffering arterial or venous thromboses in the absence of other known autoimmune diseases and also in the absence of pronounced classical risk factors. We found that IgM anti-beta2GPI positively correlated with some markers of increased coagulation potential and negatively with parameters of the metabolic syndrome. Thus, it appears that elevated levels of IgM anti-beta2GPI are linked to thrombotic disorders in young women (without autoimmune disease) particularly when classical risk factors or the metabolic syndrome are absent. 相似文献
64.
Heller F Lindenmeyer MT Cohen CD Brandt U Draganovici D Fischereder M Kretzler M Anders HJ Sitter T Mosberger I Kerjaschki D Regele H Schlöndorff D Segerer S 《The American journal of pathology》2007,170(2):457-468
Local B-cell infiltrates play a role in tissue fibrosis, neolymphangiogenesis, and renal allograft survival. We sought to characterize the B-cell infiltrates, factors involved in B-cell recruitment, and lymphangiogenesis in renal interstitial injury (ie, acute and chronic interstitial nephritis and chronic IgA nephropathy). CD20-positive B cells formed a prominent part of the interstitial infiltrating cells. Together with CD3-positive T cells, the CD20-positive B cells formed larger nodular structures. CD10-positive pre-B cells were rare, and the majority were mature CD27-positive B cells. Proliferating B cells were detected within nodular infiltrates. The level of mRNA expression of the chemokine CXCL13 was increased and correlated with CD20 mRNA in the tubulointerstitial space. CXCL13 protein was predominantly found at sites of nodular infiltrates, in association with CXCR5-positive B cells. Furthermore, sites of chronic interstitial inflammation were associated with a high number of lymphatic vessels. B-cell infiltrates form a prominent part of the interstitial infiltrates both in primary interstitial lesions and in IgA nephropathy. CXCR5-positive B cells might be recruited via the chemokine CXCL13 and seem to contribute to the formation of intrarenal lymphoid follicle-like structures. These might represent an intrarenal immune system. 相似文献
65.
66.
SimPEL: Simulation‐based power estimation for sequencing studies of low‐prevalence conditions 下载免费PDF全文
Chen Cao Paul Gordon Maja Tarailo‐Graovac Chad Bousman Pei Wang Quan Long 《Genetic epidemiology》2018,42(5):480-487
Power estimations are important for optimizing genotype‐phenotype association study designs. However, existing frameworks are designed for common disorders, and thus ill‐suited for the inherent challenges of studies for low‐prevalence conditions such as rare diseases and infrequent adverse drug reactions. These challenges include small sample sizes and the need to leverage genetic annotation resources in association analyses for the purpose of ranking potential causal genes. We present SimPEL, a simulation‐based program providing power estimations for the design of low‐prevalence condition studies. SimPEL integrates the usage of gene annotation resources for association analyses. Customizable parameters, including the penetrance of the putative causal allele and the employed pathogenic scoring system, allow SimPEL to realistically model a large range of study designs. To demonstrate the effects of various parameters on power, we estimated the power of several simulated designs using SimPEL and captured power trends in agreement with observations from current literature on low‐frequency condition studies. SimPEL, as a tool, provides researchers studying low‐frequency conditions with an intuitive and highly flexible avenue for statistical power estimation. The platform‐independent “batteries included” executable and default input files are available at https://github.com/precisionomics/SimPEL . 相似文献
67.
Stine Marie Havig Dordi Lea Maja Krpo Ragnhild Margrete Skari Ingebjørg Gustavsen Gudrun Høiseth 《Basic & clinical pharmacology & toxicology》2018,123(2):221-226
An elderly man with decreased kidney function was admitted to hospital with gastrointestinal bleeding. After remaining stable for 2 days in hospital, he became haemodynamically unstable and an adverse effect of dabigatran was suspected, but efforts to treat the patient failed and the following morning he passed away. In conjunction with the autopsy, blood samples from his hospital stay were analysed for dabigatran, revealing the highest concentration (6400 ng/mL) apparently reported to date. Supra‐therapeutic dosing was, however, never suspected. Dabigatran is largely excreted through the kidneys. A possible cause of the high dabigatran concentrations could be a rapid decrease in kidney function that seemingly occurred over a period of 2 months, sometime between his initiation of treatment (eGFR 51–55 mL/min/1.73 m2) and subsequent hospital admission (eGFR 31 mL/min/1.73 m2). The increasing dabigatran concentrations in the patient was, however, not apparent to the prescribing doctor, as therapeutic drug monitoring of dabigatran is not recommended in current guidelines and no such analyses were performed. There may be a need to evaluate blood concentrations of dabigatran, in the light of the reported differences in interindividual concentrations, along with the increased risks of thromboembolic events with lower concentrations and major bleeding events with higher concentrations. Functional assays to assess concentrations of dabigatran in blood have been developed and are available in some hospitals to be used in suspected overdoses or before emergency surgeries. Methods to determine concentrations of dabigatran specifically have also been developed and can additionally be used for therapeutic drug monitoring in an outpatient setting, especially in high‐risk individuals. 相似文献
68.
69.
Golež Aljaž Frangež Igor Cankar Ksenija Frangež Helena Ban Ovsenik Maja Nemeth Lidija 《Lasers in medical science》2022,37(2):745-758
Lasers in Medical Science - Hyposalivation is a condition represented by a reduced salivary flow and may include symptoms such as mouth dryness (xerostomia), loss of taste, pain, dysphagia, and... 相似文献
70.
Maja Lozi? Michael Greenwood Olivera ?arenac Andrew Martin Charles Hindmarch Tatjana Tasi? Julian Paton David Murphy Nina Japund?i?-?igon 《British journal of pharmacology》2014,171(19):4385-4398